Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: A pilot project

Journal of Psychiatric Research

Volumn 54, Issue 1, 2014, Pages 11-18

  Leuchter, Andrew F ^a   McGough, James J ^b   Korb, Alexander S ^a   Hunter, Aimee M ^a   Glaser, Paul E A ^c   Deldar, Ahmed ^d   Durell, Todd M ^d   Cook, Ian A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Atomoxetine; Attention deficit hyperactivity disorder (ADHD); Biomarker; Cordance; Quality of life; Quantitative electroencephalography (qEEG); Thalamocortical circuits and oscillations; Treatment response

Indexed keywords

ATOMOXETINE; PLACEBO; ADRENERGIC RECEPTOR AFFECTING AGENT; PROPYLAMINE;

ABSOLUTE POWER; ACCURACY; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORDANCE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; MALE; MULTICENTER STUDY; NEUROPHYSIOLOGY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELATIVE POWER; THETA RHYTHM; YOUNG ADULT; ADOLESCENT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DRUG EFFECTS; PATHOPHYSIOLOGY; PILOT STUDY; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN WAVES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; PILOT PROJECTS; PROPYLAMINES; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899900387     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.03.009     Document Type: Article

References (49)

1. Adler L.A., Faraone S.V., Spencer T.J., Michelson D., Reimherr F.W., Glatt S.J., et al. The reliability and validity of self- and investigator ratings of ADHD in adults. Journal of Attention Disorders 2008, 11(6):711-719.
2. Adler L.A., Liebowitz M., Kronenberger W., Qiao M., Rubin R., Hollandbeck M., et al. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depression and Anxiety 2009, 26:212-221.
3. Adler L.A., Spencer T., Brown T.E., Holdnack J., Saylor K., Schuh K., et al. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. Journal of Clinical Psychopharmocology 2009, 29:44-50.
4. Adler L.A., Spencer T., Faraone S.V., Reimherr F.W., Kelsey D., Michelson D., et al. Training raters to assess adult ADHD: reliability of ratings. Journal of Attention Disorders 2005, 8:121-126.
5. Diagnostic and Statistical Manual of Mental Disorders 2004, American Psychiatric Association, American Psychiatric Association, Washington, DC, (DSM-IV-TR). 4th ed.
6. Arns M., Gunkelman J., Breteler M., Spronk D. EEG phenotypes predict treatment outcome to stimulants in children with ADHD. Journal of Integrative Neuroscience 2008, 7(3):421-438.
7. Arnsten A.F. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology. An important role for prefrontal cortex dysfunction. CNS Drugs 2009, 1:33-41.
8. Bares M., Brunovsky M., Kopecek M., Stopkova P., Novak T., Kozeny J., et al. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. Journal of Psychiatry Research 2007, 41(3-4):319-325.
9. Bares M., Brunovsky M., Kopecek M., Novak T., Stopkova P., Kozeny J., et al. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. European Psychiatry 2008, 23(5):350-355.
10. Bares M., Brunovsky M., Novak T., Kopecek M., Stopkova P., Sos P., et al. The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. European Neuropsychopharmacology 2010, 20(7):459-466.
11. Barry R.J., Clarke A.R., Hajos M., McCarthy R., Selikowitz M., Bruggemann J.M. Acute atomoxetine effects on the EEG of children with attention-deficit/hyperactivity disorder. Neuropharmacology 2009, 57:702-709.
12. Başar E., Güntekin B. A review of brain oscillations in cognitive disorders and the role of neurotransmitters. Behavioral Brain Research 2008, 1235:172-193.
13. Brod M., Perwien A., Adler L., Spencer T., Johnston J. Conceptual model for measuring functional impairments in adults with ADHD. Primary Care Psychiatry 2005, 12:58-64.
14. Broyd S.J., Demanuele C., Debener S., Helps S.K., James C.J., Sonuga-Barke E.J. Default-mode brain dysfunction in mental disorders: a systematic review. Neuroscience and Biobehavior Reviews 2009, 33(3):279-296.
15. Chabot R.J., Orgill A.A., Crawford G., Harris M.J., Serfontein G. Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. Journal of Child Neurology 1999, 14(6):343-351.
16. Clarke A.R., Barry R.J., McCarthy R., Selikowitz M., Croft R.J. EEG differences between good and poor responders to methylphenidate in boys with the inattentive type of attention-deficit/hyperactivity disorder. Clinical Neurophysiology 2002, 113(8):1191-1198.
17. Clerkin S.M., Schulz K.P., Berwid O.G., Fan J., Newcorn J.H., Tang C.Y., et al. Thalamo-cortical activation and connectivity during response preparation in adults with persistent and remitted ADHD. American Journal of Psychiatry 2013, 170(9):1011-1019.
18. Conners C., Erhardt D., Sparrow E. Conners' adult ADHD rating scales (CAARS) 1999, Multi-Health Systems Inc, North Tonawanda.
19. Cook I.A., Hunter A.M., Abrams M., Siegman B., Leuchter A.F. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Research 2009, 174(2):152-157.
20. Cook I.A., Leuchter A.F., Morgan M., Witte E., Stubbeman W.F., Abrams M., et al. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 2002, 27(1):120-131.
21. Cook I.A., O'Hara R., Uijtdehaage S.H., Mandelkern M., Leuchter A.F. Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalography and Clinical Neurophysiology 1998, 107(6):408-414.
22. Dillo W., Goke A., Prox-Vagedes V., Szycik G.R., Roy M., Donnerstag F., et al. Neuronal correlates of ADHD in adults with evidence for compensation strategies-a functional MRI study with a Go/No-Go paradigm. German Medical Science 2010, 8. Doc09.
23. Durell T.M., Adler L.A., Williams D.W., Deldar A., McGough J.J., Glaser P.E., et al. Atomoxetine treatment of Attention-Deficit/Hyperactivity Disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology 2013, 33:45-54.
24. Hale T.S., Bookheimer S., McGough J.J., Phillips J.M., McCracken J.T. Atypical brain activation during simple and complex levels of processing in adult ADHD: an fMRI study. Journal of Attention Disorders 2007, 11:125-140.
25. Hale T.S., Smalley S.L., Hanada G., Macion J., McCracken J.T., McGough J.J., et al. Atypical alpha asymmetry in adults with ADHD. Neuropsychologia 2009, 47(10):2082-2088.
26. Hale T.S., Smalley S.L., Walshaw P.D., Hanada G., Macion J., McCracken J.T., et al. Atypical EEG beta asymmetry in adults with ADHD. Neuropsychologia 2010, 48(12):3532-3539.
27. Hughes S.W., Crunelli V. Thalamic mechanisms of EEG alpha rhythms and their pathological implications. Neuroscientist 2005, 11:357-372.
28. Hunter A.M., Ravikumar S., Cook I.A., Leuchter A.F. Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression. Acta Psychiatricia Scandinavica 2009, 119:266-273.
29. Kieling C., Genro J.P., Hutz M.H., Rohde L.A. A current update on ADHD pharmacogenomics. Pharmacogenomics 2010, 11:407-419.
30. Klimesch W., Sauseng P., Gerloff C. Enhancing cognitive performance with repetitive transcranial magnetic stimulation at human individual alpha frequency. European Journal of Neuroscience 2003, 17(5):1129-1133.
31. Kooij J.S., Boonstra A.M., Vermeulen S.H., Heister A.G., Burger H., Buitelaar J.K., et al. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). American Journal of Medical Genetics Part B- Neuropsychiatric Genetics 2008, 147B(2):201-208.
32. Leiser S.C., Dunlop J., Bowlby M.R., Devilbiss D.M. Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research. Biochemical Pharmacology 2011, 81:1408-1421.
33. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., Abrams M. Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry 2002, 159(1):122-129.
34. Leuchter A.F., Cook I.A., DeBrota D.J., Hunter A.M., Potter W.Z., McGrouther C.C., et al. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clinical EEG and Neuroscience 2008, 39:175-181.
35. Leuchter A.F., Cook I.A., Lufkin R.B., Dunkin J., Newton T.F., Cummings J.L., et al. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage 1994, 1(3):208-219.
36. Leuchter A.F., Uijtdehaage S.H., Cook I.A., O'Hara R., Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Research 1999, 90(2):125-140.
37. Loo S.K., Barkley R.A. Clinical utility of EEG in attention deficit hyperactivity disorder. Applied Neuropsychology 2005, 12:64-76.
38. Loo S.K., Teale P.D., Reite M.L. EEG correlates of methylphenidate response among children with ADHD: a preliminary report. Biological Psychiatry 1999, 45(12):1657-1660.
39. Marquand A.F., O'Daly O.G., De Simoni S., Alsop D.C., Maguire R.P., Williams S.C., et al. Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. Neuroimage 2012, 60(2):1015-1024.
40. McGough J.J., McCracken J.T., Loo S.K., Manganiello M., Leung M.C., Tietjens J.R., et al. A candidate gene analysis of methylphenidate response in attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2009, 12:1155-1164.
41. Michelson D., Allen A.J., Busner J. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. American Journal of Psychiatry 2002, 159:1896-1901.
42. Michelson D., Read H.A., Ruff D.D., Witcher J., Zhang S., McCracken J. CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:242-251.
43. Pliszka S.R., Crismon M.L., Hughes C.W. The Texas children's medication algorithm project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:642-657.
44. Prince J. Pharmacotherapy of attention-deficit/hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child and Adolescent Psychiatric Clinics of North America 2006, 15:13-50.
45. Rothenberger A. Brain oscillations forever-neurophysiology in future research of child psychiatric problems. Journal of Child Psychology and Psychiatry 2009, 50(1-2):79-86.
46. Rushworth M.F., Nixon P.D., Renowden S., Wade D.T., Passingham R.E. The left parietal cortex and motor attention. Neuropsychologia 1997, 35:1261-1273.
47. Sukhodolsky D.G., Leckman J.F., Rothenberger A., Scahill L. The role of abnormal neural oscillations in the pathophysiology of co-occurring Tourette syndrome and attention-deficit/hyperactivity disorder. European Child and Adolescent Psychiatry 2007, 16(8):537.
48. Tamm L., Menon V., Reiss A.L. Parietal attentional system aberrations during target detection in adolescents with attention deficit hyperactivity disorder: event-related fMRI evidence. American Journal of Psychiatry 2006, 163:1033-1043.
49. Xia S., Li X., Kimball A.E., Kelly M.S., Lesser I., Branch C. Thalamic shape and connectivity abnormalities in children with attention-deficit/hyperactivity disorder. Psychiatry Research 2012, 204(2-3):161-167.